VigRX Plus review

The stated rate is a 50% revenue share, with $245 per sale as the headline figure. The model is cps and revshare, so a conversion is credited on a completed order and the payout rises with order value, including upsells taken during checkout.

Payouts run Bi-weekly, so approved earnings clear more often than on a monthly statement. Publishers with steady supplement traffic find that useful, since money moves out before the next statement closes. It suits sites that earn in small but regular increments.

The offer is listed through SellHealth, which is where publishers apply for approval and tracking. Anyone already working inside that network can start promoting without new tooling, while publishers on other networks need a separate relationship before running the links.

The programme is global and sits in the health vertical, so health publishers outside the largest markets can still apply. Traffic quality matters more than origin, though local advertising rules and the wording of a supplement claim stay with the publisher.

Health and wellness programmes list cookie windows of 30 to 45 days, with a median of 30 days. A short window puts more weight on the first click, so match the window against the buying cycle in your own niche.

It fits a health publisher whose audience reads men's wellness content and buys supplements, since the offer is a health product paying 50% revenue share. It suits sites that can point repeat traffic at the same brand rather than testing a new offer every month.

TestRX lists 50% per sale, a similar rate on a different product in the same health category. VigRX Plus runs on cps and revshare with payouts Bi-weekly, so the choice turns on the product and the network rather than the headline figure.

Across the programmes tracked, the median payout threshold is €43.85, with the middle of the range running €17.54 to €87.70. VigRX Plus pays Bi-weekly, and the threshold itself is set through SellHealth.